INDY HEMATOLOGY REVIEW
Nursing & Allied Providers Agenda 2027
Recognizing the Risk, Guiding the Care: Hematology in Practice.
Saturday, March 13th, 2027
Moderator: Thalia Hammond, IHE, Director of Conventions
Registration and Opening Program
| Time | Event/Topic |
|---|---|
| 6:00 - 10:00 AM | Registration |
| 6:45 - 7:25 AM | Breakfast Product Theater |
| 7:30 - 8:00 AM | The Next Chapter in Hematology: Emerging Therapies and What They Mean for Patient Care in 2027 Ruemu E. Birhiray, MD |
| 8:00 - 8:05 AM | Transition to Nursing and Allied Provider Sessions |
| 8:05 AM - 8:35 AM | Reading the Marrow, Planning the Care: Understanding the Bone Marrow Biopsy and Next Steps in MDS Ke Yang, NP |
| 8:35 - 9:05 AM | Beyond the Hemoglobin: Medication Strategies for Anemia in Chronic Kidney Disease Aashiq Kumar, PA |
| 9:05 - 9:35 AM | The Nurse at the Center of Myeloma Care: Anticipating Needs, Recognizing Risks, and Supporting Treatment Katie French |
| 9:35 - 9:45 AM | Coffee Break, Exhibit Hall, and Return to Sessions |
| 9:45 - 10:15 AM | Care Across Borders: Lessons from a Firsthand Experience in International Hematology Madison Mosure |
| 10:15 - 10:45 AM | From Approval to Infusion: The Nurse's Role in Opening the Door to CAR T-Cell Therapy Audrey Hopper, BSN, RN, BMTCN |
| 10:45 - 11:15 AM | Sickle Cell Care Reimagined: From Disease Modification to Gene Therapy James Faulkner, MD |
| 11:15 - 11:45 AM | More Than a Check-In: Making Psychosocial Assessment a Hematology Vital Sign Sierra Akinwumi, NP |
| 11:45 AM - 12:15 PM | When the CBC Raises the Alarm: Recognizing What Needs Urgent Action Sheryl Knott, NP |
| 12:15 - 12:45 PM | New Targets, New Responsibilities: Nursing Considerations for Emerging Hematology Drugs Rowena "Moe" Schwartz, PharmD, BCOP |
Luncheon, Keynote, and Afternoon Program
| Time | Event/Topic |
|---|---|
| 12:45 - 1:20 PM | Luncheon Product Theaters |
| 1:20 - 1:25 PM | Coffee Break and Exhibit Hall |
| 1:25 - 1:30 PM | Named Sponsor Introduction |
| 1:30 - 2:10 PM | T. Howard Lee Keynote Lecture — Seeing Tomorrow, Treating Today: The Evolving Art of Prognostication in Myeloid Neoplasms Ayalew Tefferi, MD |
| 2:10 - 2:15 AM | What Will Change Practice Next? Distinguished Lecturer Panel |
| 2:15 - 2:20 PM | Transition to Nursing and Allied Provider Sessions |
| 2:20 - 2:50 PM | The Right Care in the Right Setting: Navigating Inpatient and Outpatient Classical Hematology Katherine Ploog* |
| 2:50 - 3:20 PM | At the Front Line of AML Care: The Nurse's Role in Treatment, Monitoring, and Patient Support Alexandra Pierce, NP |
| 3:20 - 3:50 PM | Redirecting T Cells, Recognizing Risk: Preventing and Managing Bispecific Antibody Toxicities Beth Romano* |
| 3:50 - 4:05 PM | Coffee Break, Exhibit Hall, and Return to Sessions |
| 4:05 - 4:35 PM | Holding Space, Protecting Yourself: Managing Stress, Grief, and Anxiety in Caregiving Meaghan Wiggins, MA, LMHC |
| 4:35 - 5:05 PM | Oral Therapy, Hands-On Vigilance: Recognizing and Managing Toxicities of Hematology Oncolytics David Reeves, PharmD, BCOP |
| 5:05 - 5:10 PM | Closing Remarks and Adjournment |
| 5:10 - 5:30 PM | Break and Transition to Nursing Product Theater |
| 5:30 - 6:00 PM | Nursing Product Theater |
| 6:00 - 7:00 PM | Nursing Reception and Hors d'Oeuvres |
| 7:00 - 8:00 PM | Hematology at the Crossroads: The Decisions We Face, the Future We Shape - 2027 Townhall Ruemu E. Birhiray, MD |